ID   CDC7_HUMAN              Reviewed;         574 AA.
AC   O00311; D3DT31; O00558; Q5T5U5;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   12-OCT-2022, entry version 210.
DE   RecName: Full=Cell division cycle 7-related protein kinase;
DE            Short=CDC7-related kinase;
DE            Short=HsCdc7;
DE            Short=huCdc7;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:27401717};
GN   Name=CDC7 {ECO:0000312|HGNC:HGNC:1745}; Synonyms=CDC7L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver, and Testis;
RX   PubMed=9250678; DOI=10.1093/emboj/16.14.4340;
RA   Sato N., Arai K., Masai H.;
RT   "Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases: in
RT   vitro phosphorylation of MCM subunits by a putative human homologue of
RT   Cdc7.";
RL   EMBO J. 16:4340-4351(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9573348; DOI=10.1016/s0378-1119(98)00094-8;
RA   Hess G.F., Drong R.F., Weiland K.L., Slightom J.L., Sclafani R.A.,
RA   Hollingsworth R.E.;
RT   "A human homolog of the yeast CDC7 gene is overexpressed in some tumors and
RT   transformed cell lines.";
RL   Gene 211:133-140(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   PubMed=9405610; DOI=10.1073/pnas.94.26.14320;
RA   Jiang W., Hunter T.;
RT   "Identification and characterization of a human protein kinase related to
RT   budding yeast Cdc7p.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14320-14325(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PRO-23; VAL-99; TRP-112;
RP   LEU-162 AND ARG-441.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH DBF4.
RX   PubMed=10373557; DOI=10.1128/mcb.19.7.5083;
RA   Kumagai H., Sato N., Yamada M., Mahony D., Seghezzi W., Lees E., Arai K.,
RA   Masai H.;
RT   "A novel growth- and cell cycle-regulated protein, ASK, activates human
RT   Cdc7-related kinase and is essential for G1/S transition in mammalian
RT   cells.";
RL   Mol. Cell. Biol. 19:5083-5095(1999).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH DBF4B.
RX   PubMed=12065429; DOI=10.1093/emboj/cdf290;
RA   Montagnoli A., Bosotti R., Villa F., Rialland M., Brotherton D.,
RA   Mercurio C., Berthelsen J., Santocanale C.;
RT   "Drf1, a novel regulatory subunit for human Cdc7 kinase.";
RL   EMBO J. 21:3171-3181(2002).
RN   [10]
RP   INTERACTION WITH DBF4B.
RX   PubMed=15668232; DOI=10.1074/jbc.m411653200;
RA   Yoshizawa-Sugata N., Ishii A., Taniyama C., Matsui E., Arai K., Masai H.;
RT   "A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for
RT   efficient progression of S and M phases.";
RL   J. Biol. Chem. 280:13062-13070(2005).
RN   [11]
RP   INTERACTION WITH DBF4 AND DBF4B.
RX   PubMed=17062569; DOI=10.1074/jbc.m604457200;
RA   Tenca P., Brotherton D., Montagnoli A., Rainoldi S., Albanese C.,
RA   Santocanale C.;
RT   "Cdc7 is an active kinase in human cancer cells undergoing replication
RT   stress.";
RL   J. Biol. Chem. 282:208-215(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27 AND THR-503, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-268, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [16]
RP   FUNCTION, INTERACTION WITH CLASPIN, CATALYTIC ACTIVITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=27401717; DOI=10.1038/ncomms12135;
RA   Yang C.C., Suzuki M., Yamakawa S., Uno S., Ishii A., Yamazaki S.,
RA   Fukatsu R., Fujisawa R., Sakimura K., Tsurimoto T., Masai H.;
RT   "Claspin recruits Cdc7 kinase for initiation of DNA replication in human
RT   cells.";
RL   Nat. Commun. 7:12135-12135(2016).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-162; MET-208; ASP-209; ARG-441; ILE-472
RP   AND ALA-498.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinase involved in initiation of DNA replication.
CC       Phosphorylates critical substrates that regulate the G1/S phase
CC       transition and initiation of DNA replication, such as MCM proteins and
CC       CLASPIN. {ECO:0000269|PubMed:12065429, ECO:0000269|PubMed:27401717}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:27401717};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000269|PubMed:27401717};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:27401717};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000269|PubMed:27401717};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Forms a complex with either DBF4/DBF4A or DBF4B, leading to
CC       the activation of the kinase activity (PubMed:10373557,
CC       PubMed:12065429, PubMed:15668232, PubMed:17062569). Interacts with
CC       CLASPIN (via the acidic patch); the interaction is required for
CC       phosphorylation of MCM proteins and CLASPIN (PubMed:27401717).
CC       {ECO:0000269|PubMed:10373557, ECO:0000269|PubMed:12065429,
CC       ECO:0000269|PubMed:15668232, ECO:0000269|PubMed:17062569,
CC       ECO:0000269|PubMed:27401717}.
CC   -!- INTERACTION:
CC       O00311; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-374980, EBI-11524452;
CC       O00311; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-374980, EBI-739580;
CC       O00311; Q9UBU7: DBF4; NbExp=8; IntAct=EBI-374980, EBI-372690;
CC       O00311; Q9UBU7-1: DBF4; NbExp=3; IntAct=EBI-374980, EBI-16017435;
CC       O00311; P51114-2: FXR1; NbExp=3; IntAct=EBI-374980, EBI-11022345;
CC       O00311; Q9UKD1: GMEB2; NbExp=3; IntAct=EBI-374980, EBI-948296;
CC       O00311; Q08379: GOLGA2; NbExp=3; IntAct=EBI-374980, EBI-618309;
CC       O00311; Q9NYA3: GOLGA6A; NbExp=3; IntAct=EBI-374980, EBI-11163335;
CC       O00311; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-374980, EBI-2549423;
CC       O00311; P42858: HTT; NbExp=3; IntAct=EBI-374980, EBI-466029;
CC       O00311; Q13422-7: IKZF1; NbExp=3; IntAct=EBI-374980, EBI-11522367;
CC       O00311; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-374980, EBI-747204;
CC       O00311; Q9H2S9: IKZF4; NbExp=3; IntAct=EBI-374980, EBI-1640423;
CC       O00311; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-374980, EBI-1216080;
CC       O00311; Q9BTE3: MCMBP; NbExp=2; IntAct=EBI-374980, EBI-749378;
CC       O00311; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-374980, EBI-16439278;
CC       O00311; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-374980, EBI-11522433;
CC       O00311; Q14140: SERTAD2; NbExp=3; IntAct=EBI-374980, EBI-2822051;
CC       O00311; O75886: STAM2; NbExp=3; IntAct=EBI-374980, EBI-373258;
CC       O00311; P55061: TMBIM6; NbExp=3; IntAct=EBI-374980, EBI-1045825;
CC       O00311; P14373: TRIM27; NbExp=3; IntAct=EBI-374980, EBI-719493;
CC       O00311; O94972: TRIM37; NbExp=3; IntAct=EBI-374980, EBI-741602;
CC       O00311; Q2TAA8: TSNAXIP1; NbExp=3; IntAct=EBI-374980, EBI-6872498;
CC       O00311; P0CW01: TSPY10; NbExp=3; IntAct=EBI-374980, EBI-19697726;
CC       O00311; Q9Y6T4: WUGSC:H_DJ0726N20.gs.b; NbExp=3; IntAct=EBI-374980, EBI-12369705;
CC       O00311; Q96DT7-3: ZBTB10; NbExp=3; IntAct=EBI-374980, EBI-12017160;
CC       O00311; Q9HCK0: ZBTB26; NbExp=3; IntAct=EBI-374980, EBI-3918996;
CC       O00311; Q8NAP8: ZBTB8B; NbExp=3; IntAct=EBI-374980, EBI-17494306;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:27401717}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms may be produced.;
CC       Name=1;
CC         IsoId=O00311-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. CDC7 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc7/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB003698; BAA19962.1; -; mRNA.
DR   EMBL; AF015592; AAC52080.1; -; mRNA.
DR   EMBL; AF005209; AAB97512.1; -; mRNA.
DR   EMBL; AY585721; AAS79323.1; -; Genomic_DNA.
DR   EMBL; AL355871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW73114.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW73115.1; -; Genomic_DNA.
DR   EMBL; BC110526; AAI10527.1; -; mRNA.
DR   EMBL; BC110527; AAI10528.1; -; mRNA.
DR   EMBL; BC111044; AAI11045.1; -; mRNA.
DR   CCDS; CCDS734.1; -. [O00311-1]
DR   RefSeq; NP_001127891.1; NM_001134419.1. [O00311-1]
DR   RefSeq; NP_001127892.1; NM_001134420.1. [O00311-1]
DR   RefSeq; NP_003494.1; NM_003503.3. [O00311-1]
DR   RefSeq; XP_005271298.1; XM_005271241.2. [O00311-1]
DR   PDB; 4F99; X-ray; 2.33 A; A=37-574.
DR   PDB; 4F9A; X-ray; 2.17 A; A/C=37-574.
DR   PDB; 4F9B; X-ray; 2.50 A; A/C=37-574.
DR   PDB; 4F9C; X-ray; 2.08 A; A=37-574.
DR   PDB; 5UWQ; X-ray; 2.28 A; D=456-473.
DR   PDB; 5UWR; X-ray; 2.24 A; D=456-478.
DR   PDB; 6YA6; X-ray; 1.44 A; A=37-467, A=534-574.
DR   PDB; 6YA7; X-ray; 1.67 A; A=37-466, A=534-574.
DR   PDB; 6YA8; X-ray; 1.79 A; A=37-467, A=534-574.
DR   PDBsum; 4F99; -.
DR   PDBsum; 4F9A; -.
DR   PDBsum; 4F9B; -.
DR   PDBsum; 4F9C; -.
DR   PDBsum; 5UWQ; -.
DR   PDBsum; 5UWR; -.
DR   PDBsum; 6YA6; -.
DR   PDBsum; 6YA7; -.
DR   PDBsum; 6YA8; -.
DR   AlphaFoldDB; O00311; -.
DR   SMR; O00311; -.
DR   BioGRID; 113914; 125.
DR   CORUM; O00311; -.
DR   DIP; DIP-31728N; -.
DR   IntAct; O00311; 59.
DR   MINT; O00311; -.
DR   STRING; 9606.ENSP00000393139; -.
DR   BindingDB; O00311; -.
DR   ChEMBL; CHEMBL5443; -.
DR   GuidetoPHARMACOLOGY; 1960; -.
DR   iPTMnet; O00311; -.
DR   PhosphoSitePlus; O00311; -.
DR   BioMuta; CDC7; -.
DR   EPD; O00311; -.
DR   jPOST; O00311; -.
DR   MassIVE; O00311; -.
DR   MaxQB; O00311; -.
DR   PaxDb; O00311; -.
DR   PeptideAtlas; O00311; -.
DR   PRIDE; O00311; -.
DR   ProteomicsDB; 47836; -. [O00311-1]
DR   Antibodypedia; 3628; 323 antibodies from 35 providers.
DR   DNASU; 8317; -.
DR   Ensembl; ENST00000234626.11; ENSP00000234626.6; ENSG00000097046.13. [O00311-1]
DR   Ensembl; ENST00000428239.5; ENSP00000393139.1; ENSG00000097046.13. [O00311-1]
DR   GeneID; 8317; -.
DR   KEGG; hsa:8317; -.
DR   MANE-Select; ENST00000234626.11; ENSP00000234626.6; NM_003503.4; NP_003494.1.
DR   UCSC; uc001doe.4; human. [O00311-1]
DR   CTD; 8317; -.
DR   DisGeNET; 8317; -.
DR   GeneCards; CDC7; -.
DR   HGNC; HGNC:1745; CDC7.
DR   HPA; ENSG00000097046; Tissue enhanced (testis).
DR   MIM; 603311; gene.
DR   neXtProt; NX_O00311; -.
DR   OpenTargets; ENSG00000097046; -.
DR   PharmGKB; PA26272; -.
DR   VEuPathDB; HostDB:ENSG00000097046; -.
DR   eggNOG; KOG1167; Eukaryota.
DR   GeneTree; ENSGT00550000075011; -.
DR   HOGENOM; CLU_000288_118_1_1; -.
DR   InParanoid; O00311; -.
DR   OMA; FYTKMDV; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; O00311; -.
DR   TreeFam; TF101052; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; O00311; -.
DR   Reactome; R-HSA-176187; Activation of ATR in response to replication stress.
DR   Reactome; R-HSA-68962; Activation of the pre-replicative complex.
DR   Reactome; R-HSA-8953750; Transcriptional Regulation by E2F6.
DR   SignaLink; O00311; -.
DR   SIGNOR; O00311; -.
DR   BioGRID-ORCS; 8317; 813 hits in 1118 CRISPR screens.
DR   ChiTaRS; CDC7; human.
DR   GeneWiki; Cell_division_cycle_7-related_protein_kinase; -.
DR   GenomeRNAi; 8317; -.
DR   Pharos; O00311; Tchem.
DR   PRO; PR:O00311; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O00311; protein.
DR   Bgee; ENSG00000097046; Expressed in secondary oocyte and 144 other tissues.
DR   ExpressionAtlas; O00311; baseline and differential.
DR   Genevisible; O00311; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC-UCL.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IDA:HGNC-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IMP:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0044770; P:cell cycle phase transition; IMP:BHF-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000727; P:double-strand break repair via break-induced replication; IBA:GO_Central.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:HGNC-UCL.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0010571; P:positive regulation of nuclear cell cycle DNA replication; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Isopeptide bond; Kinase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN           1..574
FT                   /note="Cell division cycle 7-related protein kinase"
FT                   /id="PRO_0000085763"
FT   DOMAIN          58..574
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        177
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         64..72
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         503
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        268
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         23
FT                   /note="Q -> P (in dbSNP:rs13447459)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_019255"
FT   VARIANT         99
FT                   /note="I -> V (in dbSNP:rs13447492)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_019256"
FT   VARIANT         112
FT                   /note="G -> W (in dbSNP:rs13447493)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_019257"
FT   VARIANT         162
FT                   /note="F -> L (in dbSNP:rs13447503)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4"
FT                   /id="VAR_019258"
FT   VARIANT         208
FT                   /note="I -> M (in dbSNP:rs34979509)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040403"
FT   VARIANT         209
FT                   /note="E -> D (in dbSNP:rs56327502)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040404"
FT   VARIANT         441
FT                   /note="K -> R (in dbSNP:rs13447539)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4"
FT                   /id="VAR_019259"
FT   VARIANT         472
FT                   /note="T -> I (in dbSNP:rs56381770)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040405"
FT   VARIANT         498
FT                   /note="S -> A (in dbSNP:rs35055915)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040406"
FT   CONFLICT        89
FT                   /note="L -> V (in Ref. 3; AAB97512)"
FT                   /evidence="ECO:0000305"
FT   HELIX           39..50
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           52..56
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          59..66
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          68..79
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          84..92
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           98..110
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          121..126
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          129..135
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           142..145
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   TURN            146..148
FT                   /evidence="ECO:0007829|PDB:6YA7"
FT   HELIX           151..170
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           180..182
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          183..186
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   TURN            187..190
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           209..213
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          214..217
FT                   /evidence="ECO:0007829|PDB:6YA7"
FT   TURN            352..355
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          356..359
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           361..364
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           377..379
FT                   /evidence="ECO:0007829|PDB:6YA8"
FT   HELIX           382..385
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           394..409
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          412..414
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           420..431
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           433..442
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   STRAND          445..451
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           458..466
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           534..537
FT                   /evidence="ECO:0007829|PDB:6YA7"
FT   HELIX           540..549
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   TURN            554..556
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           560..563
FT                   /evidence="ECO:0007829|PDB:6YA6"
FT   HELIX           567..569
FT                   /evidence="ECO:0007829|PDB:6YA6"
SQ   SEQUENCE   574 AA;  63888 MW;  90D549BEE20AE583 CRC64;
     MEASLGIQMD EPMAFSPQRD RFQAEGSLKK NEQNFKLAGV KKDIEKLYEA VPQLSNVFKI
     EDKIGEGTFS SVYLATAQLQ VGPEEKIALK HLIPTSHPIR IAAELQCLTV AGGQDNVMGV
     KYCFRKNDHV VIAMPYLEHE SFLDILNSLS FQEVREYMLN LFKALKRIHQ FGIVHRDVKP
     SNFLYNRRLK KYALVDFGLA QGTHDTKIEL LKFVQSEAQQ ERCSQNKSHI ITGNKIPLSG
     PVPKELDQQS TTKASVKRPY TNAQIQIKQG KDGKEGSVGL SVQRSVFGER NFNIHSSISH
     ESPAVKLMKQ SKTVDVLSRK LATKKKAIST KVMNSAVMRK TASSCPASLT CDCYATDKVC
     SICLSRRQQV APRAGTPGFR APEVLTKCPN QTTAIDMWSA GVIFLSLLSG RYPFYKASDD
     LTALAQIMTI RGSRETIQAA KTFGKSILCS KEVPAQDLRK LCERLRGMDS STPKLTSDIQ
     GHASHQPAIS EKTDHKASCL VQTPPGQYSG NSFKKGDSNS CEHCFDEYNT NLEGWNEVPD
     EAYDLLDKLL DLNPASRITA EEALLHPFFK DMSL
//
